← Leaderboards
Detra Robinson
Westat, Inc.
$15,000,418
Attributed
$15,000,418
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.6M · FY2009–22$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$15,000,418 · 2
By mechanism
N02$15,000,418 · 2
Top collaborators
No co-investigators on record.
Most similar at Westat, Inc.
Same institution · by research overlap
- Barbara Driver$270,069,085
- Russell Walker$15,990,748
- Steve Durako$1,229,437
- David Cantor$2,480,820
- Karen Martier$35,984,531
Others in their field
Top investigators on “Services”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,236,423,805
- Leonard Freedman · Leidos Biomedical Research, Inc.$868,224,440
- Larry Arthur$689,089,782
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Bambra Strokes · Ppd Development Lp$526,656,217
- Mitchell J Malone · Texas A&M Research Foundation$353,400,900
Research focus
ServicesContractorCenters For Disease Control And Prevention (U.S.)National Institute Of Neurological Disorders And StrokeUnited StatesUnited States Public Health ServiceGrowthBrain DiseasesDisease SurveillanceProgramsAttentionCohortCessation Of LifeFailureNational Institute Of Child Health And Human DevelopmentCreutzfeldt-Jakob SyndromeChildFollow-UpSomatropinNational Institute Of Diabetes And Digestive And Kidney DiseasesPhysiciansPituitary HormonesConduct Clinical TrialsEvaluation
Grant awards (9)
CREUTZFELDT-JAKOB DISEASE SURVEILLANCE IN RECIPIENTS OF HUMAN GROWTH HORMONE$258,216
N02 · FY2022 · HD · contact PI
CREUTZFELDT-JAKOB DISEASE SURVEILLANCE IN RECIPIENTS OF HUMAN GROWTH HORMONE$252,316
N02 · FY2021 · HD · contact PI
CREUTZFELDT-JAKOB DISEASE SURVEILLANCE IN RECIPIENTS OF HUMAN GROWTH HORMONE$246,534
N02 · FY2020 · HD · contact PI
CREUTZFELDT-JAKOB DISEASE SURVEILLANCE IN RECIPIENTS OF HUMAN GROWTH HORMONE$240,903
N02 · FY2019 · HD · contact PI
CREUTZFELDT-JAKOB DISEASE SURVEILLANCE IN RECIPIENTS OF HUMAN GROWTH HORMONE$235,400
N02 · FY2018 · HD · contact PI
Cancer Prevention Clinical Trials Monitoring and Informatics Support$3,400,000
N02 · FY2012 · CA · contact PI
Cancer Prevention Clinical Trials Monitoring and Informatics Support$3,616,657
N02 · FY2011 · CA · contact PI
Cancer Prevention Clinical Trials Monitoring and Informatics Support$3,482,740
N02 · FY2010 · CA · contact PI
Cancer Prevention Clinical Trials Monitoring and Informatics Support$3,267,652
N02 · FY2009 · CA · contact PI